CRBP
7:00 AM
News Updates
Tue, May 26, 2026
1 updatesThu, May 21, 2026
1 updatesThu, May 14, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
Presentation / Abstract • Phase 1/2ASCO presentation Fri, May 29, 2026corbuspharma.com
Wed, May 13, 2026
1 updatesCRBP
7:00 AM
Tue, May 12, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
Enrollment • Phase 1ASCO presentation Tue, May 12, 2026corbuspharma.com
Tue, May 5, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026
Presentation / Abstract • Phase 1/2corbuspharma.com
Wed, Apr 22, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Presentation / Abstract • Phase 1/2corbuspharma.com
Tue, Apr 14, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Enrollment • Phase 1corbuspharma.com
Tue, Apr 7, 2026
1 updatesCRBP
8:00 AM
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Presentation / Abstract • Phase 1/2corbuspharma.com
Wed, Mar 18, 2026
1 updatesCRBP
8:00 AM